Western Medicine With Traditional Chinese Medicine Syndrome Differentiation Of Idiopathic Thrombocytopenic Purpura Clinical Observation

Objective:The use of pure western, Chinese medicine combined with western syndrome differentiation of two different treatment options for idiopathic thrombocytopenic purpura, compare two different therapeutic protocols.Method:60 cases of idiopathic thrombocytopenic purpura patients were randomly divided into two groups (n=30), combined with western medicine syndrome differentiation treatment group (A group), Western Canada Chinese medicine differentiation of conventional therapy, only western medicine group (B group) only received conventional western medicine treatment. For 6 months. Observe bleeding during treatment and signs of changes in platelet count for each check once a week. Platelet count before and after treatment and life, bone marrow megakaryocytes produce plate number, and other indicators of changes in platelet antibodiesResults:X2 test with synthetic effect, A group and B group P>0.05, suggest no significant difference between two groups, but the effective and efficient group A than group B 6.6%.Symptomatic efficacy of Chinese medicine using X2 test, A group and B group P<0.05, significant difference between the two groups suggest that Chinese medicine Clinical symptoms were significantly better than the B A group.The two groups could significantly improve platelet count before treatment between the two groups as P>0.05, suggest no significant difference between the two groups before treatment, both groups before and after treatment within each group compared to P<0.01, suggest a significant difference in treatment group Comparison between P<0.01, A group in raising platelet count has obvious advantages.PAIgG on platelet antibodies measured before treatment between the two groups as P>0.05, suggest no significant difference before treatment, both groups before and after treatment within each group compared to P<0.01, suggest a significant difference before and after treatment in reducing platelet antibody PAIgG area After treatment groups was compared P>0.05, not statistically significant.Before and after treatment for determination of platelet life span, between the two groups before treatment, P>0.05, suggest no significant difference between the two groups before treatment, both groups before and after treatment within each group compared to P<0.01, significantly different tips, suggesting that both groups PLS have extended treatment groups was compared P<0.01, in extended longevity platelets, A group was significantly better than the B group.On bone marrow megakaryocyte number plate production measured before treatment between the two groups P> 0.05, suggest no significant difference between the two groups before treatment, both groups before and after treatment P<0.01, suggest a significant difference in improving the production of bone marrow megakaryocyte number plate, the treatment group compared P>0.05, not statistically significant.Side-effects on, A group of side effects is significantly less than the B group.Conclusion:Differential Treatment of Chinese medicine combined with western treatment of the disease can be significantly increased platelet count, platelet life extension to reduce the side effects of corticosteroids, so treatment can be combined with western medicine syndrome differentiation attenuated efficiency, more effective than western medicine only.